ArticleBMC neurology2010
Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
Article in BMC neurology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.
- Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Guideline
- Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).The American journal of tropical medicine and hygiene · 2018Guideline
- Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.The Lancet. Infectious diseases · 2014Trial
- An Integrated Approach of Proteomic, Cheminformatic, and In Vitro Drug Screening to Identify Potential Therapeutic Targets ofACS omega · 2025Article
- Long-Term Neuroimaging Findings in a Murine Model of Human Extraparenchymal Neurocysticercosis.ACS infectious diseases · 2025Article
- Obstructive hydrocephalus: when subarachnoid cysts alert to the challenging diagnosis of neurocysticercosis.Quantitative imaging in medicine and surgery · 2025Article
- Murine Extraparenchymal Neurocysticercosis: Appropriate Model for Evaluating Anthelminthic and Anti-Inflammatory Treatment Schedules.Tropical medicine and infectious disease · 2024Article
- Current Role of Surgery in the Treatment of Neurocysticercosis.Pathogens (Basel, Switzerland) · 2024Review
- Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.Infection · 2023Article
- Subarachnoid racemose neurocysticercosis with cerebellar involvement: an old friend in an infrequent location?Revista do Instituto de Medicina Tropical de Sao Paulo · 2021Article
- A Clinical Prognostic Scoring System for Neurocysticercosis.Journal of neurosciences in rural practice · 2021Article
- Subarachnoid neurocysticercosis: emerging concepts and treatment.Current opinion in infectious diseases · 2020Review
- Natural History of Treated Subarachnoid Neurocysticercosis.The American journal of tropical medicine and hygiene · 2020Article
- Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features.PLoS neglected tropical diseases · 2017Article
- Under seize: neurocysticercosis in an immigrant woman and review of a growing neglected disease.BMJ case reports · 2015Review
- Managing neurocysticercosis: challenges and solutions.International journal of general medicine · 2015Review
- Taenia solium: Development of an Experimental Model of Porcine Neurocysticercosis.PLoS neglected tropical diseases · 2015Article
- Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity.Medical microbiology and immunology · 2014Article
- Neurocysticercosis: HP10 antigen detection is useful for the follow-up of the severe patients.PLoS neglected tropical diseases · 2013Article
- Commentary.Journal of neurosciences in rural practice · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeurocysticercosis (NC) is one of the most frequent parasitic diseases of the central nervous system. Cysticidal drugs, albendazole and praziquantel, are generally effective when parasites localize in the parenchyma. In contrast, parasites lodged in the subarachnoid basal cisterns are less responsive to treatment. CASE PRESENTATION: The clinical and radiological pictures of six Mexican patients non-respondent to cysticidal treatment are presented.
conclusionsThe possible factors involved in the cysticidal non-response are discussed and hints are provided of potentially useful changes to therapeutic protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.